# OnCo record paper-bilcap-lancet-oncol-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-bilcap-lancet-oncol-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-bilcap-lancet-oncol-2019" ;
  schema:name "BILCAP: capecitabine compared with observation in resected biliary tract cancer"@en ;
  schema:description "Six months of capecitabine tablets after surgery for bile duct or gallbladder cancer lengthened survival by about a year in the per-protocol analysis, and became the standard adjuvant treatment despite narrowly missing its primary endpoint."@en ;
  schema:url <https://onco.cc/key-papers/paper-bilcap-lancet-oncol-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(18)30915-X>, <https://pubmed.ncbi.nlm.nih.gov/30922733/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(18)30915-X> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Primrose JN, Fox RP, Palmer DH, et al." ;
  onco:cancers <https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/>, <https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/> ;
  onco:trials <https://onco.cc/trials/bilcap/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .